Octreotide acetate and Losartan potassium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Octreotide acetate (octreotide acetate) and Losartan potassium (losartan potassium). Common drug interactions include back pain among females and alanine aminotransferase increased among males.

The phase IV clinical study analyzes what interactions people have when they take Octreotide acetate and Losartan potassium. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Octreotide acetate?

Octreotide acetate has active ingredients of octreotide acetate. eHealthMe is studying from 2,449 Octreotide acetate users. Check the latest studies of Octreotide acetate.

What is Losartan potassium?

Losartan potassium has active ingredients of losartan potassium. It is often used in high blood pressure. eHealthMe is studying from 51,513 Losartan potassium users. Check the latest studies of Losartan potassium.

On Aug, 07, 2026

17 people who take Octreotide acetate and Losartan potassium together, and have interactions are studied.

Octreotide acetate and Losartan potassium drug interactions.

What are the common drug interactions of Octreotide Acetate and Losartan Potassium, by gender? *:

female:

Back pain
Viral infection
Blood pressure fluctuation
Death
Dehydration (dryness resulting from the removal of water)
Headache (pain in head)
Sciatica (a set of symptoms including pain caused by general compression or irritation of one of five spinal nerve roots of each sciatic nerve)
Thyroid disorder (thyroid diseases)
Urinary tract infection
Weight decreased

male:

Alanine aminotransferase increased
Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
Confusional state
Fall
Fatigue (feeling of tiredness)
International normalised ratio increased
Myalgia (muscle pain)
Neoplasm recurrence (reoccurrence of tumour)
Night sweats (sweating in night)
Pyrexia (fever)

What are the common drug interactions of Octreotide Acetate and Losartan Potassium, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Viral infection
Asthenia (weakness)
Arthralgia (joint pain)
Aspartate aminotransferase increased
Ataxia (loss of full control of bodily movements)
Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
Blood alkaline phosphatase increased
Blood bilirubin increased
Blood creatinine increased
Blood pressure fluctuation

What are the existing conditions these people have? *

Carcinoid Syndrome (syndrome includes flushing and diarrhoea, and, less frequently, heart failure and bronchoconstriction): 8 people, 47.06%
Carcinoid Tumor: 4 people, 23.53%
Short-Bowel Syndrome (a condition in which the body cannot absorb enough fluids and nutrients because part of the small intestine is missing): 2 people, 11.76%
Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 1 person, 5.88%
Pancreatic Neuroendocrine Tumor: 1 person, 5.88%
Pain: 1 person, 5.88%
Neurotrophic Keratopathy (decreased corneal sensitivity and poor corneal healing): 1 person, 5.88%
Muscle Spasms (muscle contraction): 1 person, 5.88%
Cardiac Failure: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Octreotide acetate and Losartan potassium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously